ArticleInterventional cardiology (London, England)2026
Mid-term Electrical Remodelling in Surface ECG Following Percutaneous Patent Foramen Ovale Closure.
Article in Interventional cardiology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Controversy exists around AF risk after patent foramen ovale (PFO) closure. This study characterised dynamic ECG changes over 6 months after Amplatzer closure, focusing on electrical remodelling. Methods: In all, 246 PFO patients underwent serial ECGs (P wave dispersion [PWD], PR interval, QRS, corrected QT interval [QTc]) and echocardiography before PFO closure and 24 hours and 1, 3 and 6 months after closure. Temporal changes were analysed. Subgroup analyses evaluated ECG changes according to comorbidity (migraine or cerebral infarction). Results: PWD increased significantly at 24 hours and peaked at 1 month, remaining elevated compared with baseline at 6 months (p<0.001). Of all patients, 5.3% had PWD ≥40 ms. The PR interval was significantly shortened after PFO closure, with this persisting at 6 months (p<0.001). AF occurred in six (2.4%) patients and supraventricular tachycardia occurred in eight (3.3%). QRS and QTc were stable. With regard to cardiac structure/function, no significant echocardiographic changes were seen from before to after PFO closure. In subgroups analyses, PR shortening was greater in patients with migraine than in those with cerebral infarction (p<0.001). Conclusion: PFO closure induced a transient elevation in PWD and sustained PR shortening. Under limited spot ECG monitoring, no clinically significant arrhythmias or structural changes were detected. However, extended surveillance is warranted to evaluate potential late-onset arrhythmogenic sequelae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.